Definitive Contract VA24017C0062
Award Date 5/8/17
Potential Completion Date 8/7/17
Potential Value $190K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Decatur, GA 30033, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration has awarded a $66,634.10 firm fixed-price purchase order to Harvard Bioscience Inc., a self-certified small disadvantaged business, for the provision of a Harvard Wireless Rodent Electrophysiology System. This equipment will be utilized at the Nashville VA Medical Center to support the agency's biomedical research initiatives. The contract, which has a completion date of September 30, 2024, was awarded under a total small business...
- This federal contract award to Harvard Bioscience Inc. (Harvard Apparatus Division) is for the procurement of a Microelectrode Array (MEA) System. The contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) and has a firm fixed price of $129,610.55. Harvard Bioscience is a global developer, manufacturer, and marketer of specialized products, apparatus, and scientific instruments used for basic research, drug discovery, clinical and...
- This is a $152,430.00 firm fixed price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Harvard Bioscience Inc.'s Harvard Apparatus Division, a self-certified small disadvantaged business. The contract is for the Wireless 2100 System, a specialized digital in vivo electrophysiology recording system capable of wireless optogenetic and electric stimulation. The contract has a completion date of March 31, 2023 and does not have a set-aside...
- This firm-fixed-price purchase order was awarded to Harvard Bioscience Inc., a self-certified small disadvantaged business, by the U.S. Department of Veterans Affairs (VA) to provide stereotaxic instruments to support research services at the VA San Diego Healthcare System. The contract has a ceiling value of $16,478.00 and a completion date of October 14, 2024. Harvard Bioscience has a long history of providing specialized scientific equipment and instruments to various federal agencies,...
- This firm fixed-price purchase order contract was awarded by the U.S. Army Medical Command (MEDCOM) to Harvard Bioscience Inc., a self-certified small disadvantaged business, for the "WORKING HEART OPTION" requirement. The $15,137.18 contract supports the provision of specialized scientific products, apparatus, and instruments used in biomedical research across various disciplines such as neuroscience, oncology, and cardiovascular studies. Harvard Bioscience holds a $4.8 million...
- This federal contract award is for the procurement of a BTX GEMINI X2 SYSTEM from Harvard Bioscience Inc.'s Harvard Apparatus Division. The $9,040.50 firm fixed-price purchase order was awarded on August 31, 2016 by the Northeast Area division of a civilian federal agency, with an ultimate completion date of September 30, 2016. The contract does not have a set-aside designation. Harvard Bioscience Inc. is a global developer, manufacturer, and marketer of specialized scientific products,...
- The Defense Health Agency awarded a $24,984.47 firm fixed-price blanket purchase agreement (BPA) call order to Harvard Bioscience Inc., operating as Data Sciences International, on January 22, 2025. This task order is issued under Harvard Bioscience's existing single-award BPA with the Defense Health Agency, valued at $4.8 million and awarded in May 2022 with completion through May 3, 2027. The procurement provides items required to complete research milestones for Dr. Myers' REACT project,...
- This is a $24,516.05 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI) to Harvard Bioscience Inc., through its Harvard Apparatus Division. The contract is for the delivery of specialized scientific equipment, with no set-aside designation. Harvard Bioscience is a global developer, manufacturer, and marketer of scientific products and instruments used in biomedical research across various disciplines, including neuroscience, oncology, and cardiovascular...
- Harvard Bioscience Inc., operating through its Data Sciences International division, received a Blanket Purchase Agreement (BPA) call order valued at $8,320.00 from the Defense Health Agency on May 4, 2022, with an ultimate completion date of July 31, 2023. This firm fixed-price task order was issued under Harvard Bioscience's single-award, $4.8 million BPA with the Defense Health Agency, which was awarded on the same date with a completion extending through May 3, 2027. The call order...
- Harvard Bioscience Inc., operating through its Data Sciences International division, received a $143,577 firm fixed-price Blanket Purchase Agreement (BPA) call order from the U.S. Army Medical Command on July 27, 2022, for telemetry software and systems. The award was issued without a set-aside designation and is scheduled for completion by August 31, 2022. Performance will be conducted at the company's Mounds View, Minnesota facility. This call order represents one task order within Harvard...